1. Home
  2. IOTR vs RADX Comparison

IOTR vs RADX Comparison

Compare IOTR & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOTR
  • RADX
  • Stock Information
  • Founded
  • IOTR 2019
  • RADX 2021
  • Country
  • IOTR Singapore
  • RADX Australia
  • Employees
  • IOTR N/A
  • RADX N/A
  • Industry
  • IOTR
  • RADX
  • Sector
  • IOTR
  • RADX
  • Exchange
  • IOTR NYSE
  • RADX NYSE
  • Market Cap
  • IOTR 29.5M
  • RADX 31.8M
  • IPO Year
  • IOTR 2025
  • RADX N/A
  • Fundamental
  • Price
  • IOTR $0.92
  • RADX $4.05
  • Analyst Decision
  • IOTR
  • RADX Strong Buy
  • Analyst Count
  • IOTR 0
  • RADX 1
  • Target Price
  • IOTR N/A
  • RADX $15.00
  • AVG Volume (30 Days)
  • IOTR 2.1M
  • RADX 37.7K
  • Earning Date
  • IOTR 01-01-0001
  • RADX 02-26-2025
  • Dividend Yield
  • IOTR N/A
  • RADX N/A
  • EPS Growth
  • IOTR N/A
  • RADX N/A
  • EPS
  • IOTR N/A
  • RADX N/A
  • Revenue
  • IOTR $9,578,336.00
  • RADX $204,609.00
  • Revenue This Year
  • IOTR N/A
  • RADX N/A
  • Revenue Next Year
  • IOTR N/A
  • RADX N/A
  • P/E Ratio
  • IOTR N/A
  • RADX N/A
  • Revenue Growth
  • IOTR 13.93
  • RADX N/A
  • 52 Week Low
  • IOTR $0.80
  • RADX $3.50
  • 52 Week High
  • IOTR $5.98
  • RADX $50.82
  • Technical
  • Relative Strength Index (RSI)
  • IOTR N/A
  • RADX N/A
  • Support Level
  • IOTR N/A
  • RADX N/A
  • Resistance Level
  • IOTR N/A
  • RADX N/A
  • Average True Range (ATR)
  • IOTR 0.00
  • RADX 0.00
  • MACD
  • IOTR 0.00
  • RADX 0.00
  • Stochastic Oscillator
  • IOTR 0.00
  • RADX 0.00

About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Share on Social Networks: